SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Agouron Pharmaceuticals (AGPH) -- Ignore unavailable to you. Want to Upgrade?

To: Miljenko Zuanic who wrote (3475)12/30/1997 5:10:00 PM
From: ALL  Respond to of 6136
 
I would pose that we may be seeing some tax-loss selling. While some would argue tax-loss selling would require a significant reduction of stock price versus the average of the past two years, three consecutive years of gains might influence some investors to sell AGPH for tax benefits. Given the biotech indexes and VRTX are significantly up today, any ideas??



To: Miljenko Zuanic who wrote (3475)12/30/1997 5:34:00 PM
From: David S.  Read Replies (1) | Respond to of 6136
 
You assume that product sales are...an all or nothing response. That's OK, since many people make the same assumption. It simplifies complex problems.


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News